Molecular Oncology
Volume 2, Issue 4 , Pages 356-367 , December 2008

The CALM and CALM/AF10 interactor CATS is a marker for proliferation

  • Leticia Fröhlich Archangelo

      Affiliations

    • Department of Medicine III, University of Munich Hospital Grosshadern and Clinical Cooperative Group Leukemia, German Research Center for Environmental Health, Marchioninistrasse 25, 81377 Munich, Germany
    • Hematology and Hemotherapy Center, State University of Campinas (UNICAMP), Carlos Chagas 480, 13083-970 Campinas-SP, Brazil
    • ,
  • Philipp A. Greif

      Affiliations

    • Department of Medicine III, University of Munich Hospital Grosshadern and Clinical Cooperative Group Leukemia, German Research Center for Environmental Health, Marchioninistrasse 25, 81377 Munich, Germany
    • ,
  • Michael Hölzel

      Affiliations

    • Institute of Clinical Molecular Biology and Tumor Genetics, German Research Center for Environmental Health, Marchioninistrasse 25, 81377 Munich, Germany
    • Present address: Division of Molecular Carcinogenesis/H2, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.
    • ,
  • Thomas Harasim

      Affiliations

    • Institute of Clinical Molecular Biology and Tumor Genetics, German Research Center for Environmental Health, Marchioninistrasse 25, 81377 Munich, Germany
    • ,
  • Elisabeth Kremmer

      Affiliations

    • Institute of Molecular Immunology, German Research Center for Environmental Health, Marchioninistrasse 25, 81377 Munich, Germany
    • ,
  • Gerhard K.H. Przemeck

      Affiliations

    • Institute of Experimental Genetics, German Research Center for Environmental Health, Ingolstädter Landstrasse 1, 85764 Neuherberg, Germany
    • ,
  • Dirk Eick

      Affiliations

    • Institute of Molecular Immunology, German Research Center for Environmental Health, Marchioninistrasse 25, 81377 Munich, Germany
    • ,
  • Aniruddha Jayant Deshpande

      Affiliations

    • Department of Medicine III, University of Munich Hospital Grosshadern and Clinical Cooperative Group Leukemia, German Research Center for Environmental Health, Marchioninistrasse 25, 81377 Munich, Germany
    • ,
  • Christian Buske

      Affiliations

    • Department of Medicine III, University of Munich Hospital Grosshadern and Clinical Cooperative Group Leukemia, German Research Center for Environmental Health, Marchioninistrasse 25, 81377 Munich, Germany
    • ,
  • Martin Hrabé de Angelis

      Affiliations

    • Institute of Experimental Genetics, German Research Center for Environmental Health, Ingolstädter Landstrasse 1, 85764 Neuherberg, Germany
    • ,
  • Sara Teresinha Olalla Saad

      Affiliations

    • Hematology and Hemotherapy Center, State University of Campinas (UNICAMP), Carlos Chagas 480, 13083-970 Campinas-SP, Brazil
    • ,
  • Stefan K. Bohlander

      Affiliations

    • Department of Medicine III, University of Munich Hospital Grosshadern and Clinical Cooperative Group Leukemia, German Research Center for Environmental Health, Marchioninistrasse 25, 81377 Munich, Germany
    • Corresponding Author InformationCorresponding author. Department of Medicine III, Grosshadern Hospital, Marchioninistrasse 15, 81377 Munich, Germany. Tel.: +49 (0)89 7099 357; fax: +49 (0)89 7095 5551.

Received 2 May 2008 ,Revised 26 August 2008 ,Accepted 27 August 2008.

References 

  1. Archangelo LF, Glasner J, Krause A, Bohlander SK. The novel CALM interactor CATS influences the subcellular localization of the leukemogenic fusion protein CALM/AF10. Oncogene. 2006;25(29):4099–4109
  2. Asnafi V, Radford-Weiss I, Dastugue N, Bayle C, Leboeuf D, Charrin C, et al CALM-AF10 is a common fusion transcript in T-ALL and is specific to the TCRgammadelta lineage. Blood. 2003;102(3):1000–1006
  3. Asnafi V, Beldjord K, Libura M, Villarese P, Millien C, Ballerini P, et al Age-related phenotypic and oncogenic differences in T-cell acute lymphoblastic leukemias may reflect thymic atrophy. Blood. 2004;104(13):4173–4180
  4. Asnafi V, Buzyn A, Thomas X, Huguet F, Vey N, Boiron JM, et al Impact of TCR status and genotype on outcome in adult T-cell acute lymphoblastic leukemia: a LALA-94 study. Blood. 2005;105(8):3072–3078
  5. Ayton PM, Cleary ML. Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins. Oncogene. 2001;20(40):5695–5707
  6. Bohlander SK, Muschinsky V, Schrader K, Siebert R, Schlegelberger B, Harder L, et al Molecular analysis of the CALM/AF10 fusion: identical rearrangements in acute myeloid leukemia, acute lymphoblastic leukemia and malignant lymphoma patients. Leukemia. 2000;14(1):93–99
  7. Carlson KM, Vignon C, Bohlander S, Martinez-Climent JA, Le Beau MM, Rowley JD. Identification and molecular characterization of CALM/AF10fusion products in T cell acute lymphoblastic leukemia and acute myeloid leukemia. Leukemia. 2000;14(1):100–104
  8. Caudell D, Aplan PD. The role of CALM-AF10 gene fusion in acute leukemia. 2007;Leukemia PMID: 18094714
  9. Caudell D, Zhang Z, Chung YJ, Aplan PD. Expression of a CALM-AF10 fusion gene leads to Hoxa cluster overexpression and acute leukemia in transgenic mice. Cancer Res. 2007;67(17):8022–8031
  10. Chao MM, Walker AC, Pendergast MB, Bohlander SK, Wechsler DS. Perturbed endocytosis by CALM-containing fusion proteins: a leukemogenic mechanism in AML. Blood. 2004;104(11):922a–923a
  11. Chao MM, Erichsen DA, Krajewski ML, Bohlander SK, Wechsler DS. Perturbed endocytosis by leukemogenic CALM-containing fusion proteins is associated with prolonged growth factor signaling and enhanced cellular proliferation. Blood. 2005;106(11):696a
  12. De Camilli P, Chen H, Hyman J, Panepucci E, Bateman A, Brunger AT. The ENTH domain. FEBS Lett. 2002;513(1):11–18
  13. Debernardi S, Bassini A, Jones LK, Chaplin T, Linder B, de Bruijn DR, et al. The MLL fusion partner AF10 binds GAS41, a protein that interacts with the human SWI/SNF complex. Blood. 2002;99(1):275–281
  14. Deshpande AJ, Cusan M, Rawat VP, Reuter H, Krause A, Pott C, et al Acute myeloid leukemia is propagated by a leukemic stem cell with lymphoid characteristics in a mouse model of CALM/AF10-positive leukemia. Cancer Cell. 2006;10(5):363–374
  15. Di Fiore PP, De Camilli P. Endocytosis and signaling. an inseparable partnership. Cell. 2001;106(1):1–4
  16. Dik WA, Brahim W, Braun C, Asnafi V, Dastugue N, Bernard OA, et al. CALM-AF10+T-ALL expression profiles are characterized by overexpression of HOXA and BMI1 oncogenes. Leukemia. 2005;19(11):1948–1957
  17. DiMartino JF, Ayton PM, Chen EH, Naftzger CC, Young BD, Cleary ML. The AF10 leucine zipper is required for leukemic transformation of myeloid progenitors by MLL-AF10. Blood. 2002;99(10):3780–3785
  18. Dreyling MH, Martinez-Climent JA, Zheng M, Mao J, Rowley JD, Bohlander SK. The t(10;11)(p13;q14) in the U937 cell line results in the fusion of the AF10 gene and CALM, encoding a new member of the AP-3 clathrin assembly protein family. Proc. Natl. Acad. Sci. U.S.A. 1996;93(10):4804–4809
  19. Dreyling MH, Schrader K, Fonatsch C, Schlegelberger B, Haase D, Schoch C, et al MLL and CALM are fused to AF10 in morphologically distinct subsets of acute leukemia with translocation t(10;11): both rearrangements are associated with a poor prognosis. Blood. 1998;91(12):4662–4667
  20. Evans PR, Owen DJ. Endocytosis and vesicle trafficking. Curr. Opin. Struct. Biol. 2002;12(6):814–821
  21. Floyd S, De Camilli P. Endocytosis proteins and cancer: a potential link?. Trends Cell Biol. 1998;8(8):299–301
  22. Ford MG, Pearse BM, Higgins MK, Vallis Y, Owen DJ, Gibson A, et al. Simultaneous binding of PtdIns(4,5)P2 and clathrin by AP180 in the nucleation of clathrin lattices on membranes. Science. 2001;291(5506):1051–1055
  23. Ford MG, Mills IG, Peter BJ, Vallis Y, Praefcke GJ, Evans PR, et al. Curvature of clathrin-coated pits driven by epsin. Nature. 2002;419(6905):361–366
  24. Forissier S, Razanajaona D, Ay AS, Martel S, Bartholin L, Rimokh R. AF10 dependent transcription is enhanced by its interaction with FLRG. Biol. Cell. 2007;99(10):563–571
  25. Greif PA, Tizazu B, Krause A, Kremmer E, Bohlander SK. The leukemogenic CALM/AF10 fusion protein alters the subcellular localization of the lymphoid regulator Ikaros. Oncogene. 2008;27(20):2886–2896
  26. Harel A, Wu F, Mattson MP, Morris CM, Yao PJ. Evidence for CALM in directing VAMP2 trafficking. Traffic. 2008;9(3):417–429
  27. Holzel M, Rohrmoser M, Schlee M, Grimm T, Harasim T, Malamoussi A, et al Mammalian WDR12 is a novel member of the Pes1-Bop1 complex and is required for ribosome biogenesis and cell proliferation. J. Cell Biol. 2005;170(3):367–378
  28. Huang F, Khvorova A, Marshall W, Sorkin A. Analysis of clathrin-mediated endocytosis of epidermal growth factor receptor by RNA interference. J. Biol. Chem. 2004;279(16):16657–16661
  29. Kalthoff C, Alves J, Urbanke C, Knorr R, Ungewickell EJ. Unusual structural organization of the endocytic proteins AP180 and epsin 1. J. Biol. Chem. 2002;277(10):8209–8216
  30. Klebig ML, Wall MD, Potter MD, Rowe EL, Carpenter DA, Rinchik EM. Mutations in the clathrin-assembly gene Picalm are responsible for the hematopoietic and iron metabolism abnormalities in fit1 mice. Proc. Natl. Acad. Sci. U.S.A. 2003;100(14):8360–8365
  31. Krause A, Kohlmann A, Haferlach T, Schoch C, Schnittger S, Mecucci C, et al. The CALM/AF10 fusion: molecular analysis of the fusion transcripts in 13 cases of AML and ALL; gene expression profiling reveals HOX gene deregulation. Blood. 2004;104(11):791a
  32. Kumon K, Kobayashi H, Maseki N, Sakashita A, Sakurai M, Tanizawa A, et al. Mixed-lineage leukemia with t(10;11)(p13;q21): an analysis of AF10-CALM and CALM-AF10 fusion mRNAs and clinical features. Genes Chromosomes Cancer. 1999;25(1):33–39
  33. Linder B, Newman R, Jones LK, Debernardi S, Young BD, Freemont P, et al. Biochemical analyses of the AF10 protein: the extended LAP/PHD-finger mediates oligomerisation. J. Mol. Biol. 2000;299(2):369–378
  34. Linder B, Gerlach N, Jackle H. The Drosophila homolog of the human AF10 is an HP1-interacting suppressor of position effect variegation. EMBO Rep. 2001;2(3):211–216
  35. Maggi LB, Weber JD. Nucleolar adaptation in human cancer. Cancer Invest. 2005;23(7):599–608
  36. Meyerholz A, Hinrichsen L, Groos S, Esk PC, Brandes G, Ungewickell EJ. Effect of clathrin assembly lymphoid myeloid leukemia protein depletion on clathrin coat formation. Traffic. 2005;6(12):1225–1234
  37. Milani V, Frankenberger B, Heinz O, Brandl A, Ruhland S, Issels RD, et al. Melanoma-associated antigen tyrosinase but not Melan-A/MART-1 expression and presentation dissociate during the heat shock response. Int. Immunol. 2005;17(3):257–268
  38. Narita M, Shimizu K, Hayashi Y, Taki T, Taniwaki M, Hosoda F, et al Consistent detection of CALM-AF10 chimaeric transcripts in haematological malignancies with t(10;11)(p13;q14) and identification of novel transcripts. Br. J. Haematol. 1999;105(4):928–937
  39. Okada Y, Feng Q, Lin Y, Jiang Q, Li Y, Coffield VM, et al. hDOT1L links histone methylation to leukemogenesis. Cell. 2005;121(2):167–178
  40. Okada Y, Jiang Q, Lemieux M, Jeannotte L, Su L, Zhang Y. Leukaemic transformation by CALM-AF10 involves upregulation of Hoxa5 by hDOT1L. Nat. Cell Biol. 2006;8(9):1017–1024
  41. Olson MO. Sensing cellular stress: another new function for the nucleolus?. Sci. STKE. 2004;224:pe10;2004
  42. Pasalic Z, Tizazu B, Archangelo L, Krause A, Greif PA, Bohlander SK. The four and a half LIM domain protein 2 (FHL2) interacts with CALM and is highly expressed in AML with complex aberrant karyotpes. Blood. 2006;108(11):4337
  43. Perrin L, Dura JM. Molecular genetics of the Alhambra (Drosophila AF10) complex locus of Drosophila. Mol. Genet. Genomics. 2004;272(2):156–161
  44. Perrin L, Bloyer S, Ferraz C, Agrawal N, Sinha P, Dura JM. The leucine zipper motif of the Drosophila AF10 homologue can inhibit pre-mediated repression: implications for leukemogenic activity of human MLL-AF10 fusions. Mol. Cell. Biol. 2003;23(1):119–130
  45. Polo S, Pece S, Di Fiore PP. Endocytosis and cancer. Curr. Opin. Cell Biol. 2004;16(2):156–161
  46. Rubbi CP, Milner J. Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses. Embo J. 2003;22(22):6068–6077
  47. Ruggero D, Pandolfi PP. Does the ribosome translate cancer?. Nat. Rev. Cancer. 2003;3(3):179–192
  48. Saha V, Chaplin T, Gregorini A, Ayton P, Young BD. The leukemia-associated-protein (LAP) domain, a cysteine-rich motif, is present in a wide range of proteins, including MLL, AF10, and MLLT6 proteins. Proc. Natl. Acad. Sci. U.S.A. 1995;92(21):9737–9741
  49. Soulier J, Clappier E, Cayuela JM, Regnault A, Garcia-Peydro M, Dombret H, et al. HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL). Blood. 2005;106(1):274–286
  50. Sporle R, Schughart K. Paradox segmentation along inter- and intrasomitic borderlines is followed by dysmorphology of the axial skeleton in the open brain (opb) mouse mutant. Dev. Genet. 1998;22(4):359–373
  51. Tebar F, Bohlander SK, Sorkin A. Clathrin assembly lymphoid myeloid leukemia (CALM) protein: localization in endocytic-coated pits, interactions with clathrin, and the impact of overexpression on clathrin-mediated traffic. Mol. Biol. Cell. 1999;10(8):2687–2702
  52. Visseren MJ, van Elsas A, van der Voort EI, Ressing ME, Kast WM, Schrier PI, et al. CTL specific for the tyrosinase autoantigen can be induced from healthy donor blood to lyse melanoma cells. J. Immunol. 1995;154(8):3991–3998
  53. Wechsler DS, Engstrom LD, Alexander BM, Motto DG, Roulston D. A novel chromosomal inversion at 11q23 in infant acute myeloid leukemia fuses MLL to CALM, a gene that encodes a clathrin assembly protein. Genes Chromosomes Cancer. 2003;36(1):26–36
  54. Whitfield ML, Zheng LX, Baldwin A, Ohta T, Hurt MM, Marzluff WF. Stem-loop binding protein, the protein that binds the 3′ end of histone mRNA, is cell cycle regulated by both translational and posttranslational mechanisms. Mol. Cell. Biol. 2000;20(12):4188–4198

PII: S1574-7891(08)00114-2

doi: 10.1016/j.molonc.2008.08.001

Molecular Oncology
Volume 2, Issue 4 , Pages 356-367 , December 2008

Article Tools

* Image Usage & Resolution